title: Primary aldosteronism: A Japanese perspective.
abstract: Primary aldosteronism (PA) is the most common cause of secondary hypertension, accounting for 10% of all hypertension. Far from being benign, hypertension due to PA is associated with high cardiovascular morbidity and mortality. However, PA is still underdiagnosed in general practice. Recent reports strongly recommend that identifying patients with PA is cost-beneficial based on improved cardiovascular outcomes afforded by specific surgical and medical treatment. This review provides an update of PA including controversial aspects of diagnosis and treatment.
authors.affiliation: Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Hospital, Sendai, Miyagi, Japan. fsatoh@mail.tains.tohoku.ac.jp
authors.forename: Fumitoshi
authors.initials: F
authors.lastname: Satoh
authors.forename: Ryo
authors.initials: R
authors.lastname: Morimoto
authors.forename: Yoshitsugu
authors.initials: Y
authors.lastname: Iwakura
authors.forename: Yoshikiyo
authors.initials: Y
authors.lastname: Ono
authors.forename: Masataka
authors.initials: M
authors.lastname: Kudo
authors.forename: Kei
authors.initials: K
authors.lastname: Takase
authors.forename: Sadayoshi
authors.initials: S
authors.lastname: Ito
mesh_terms: D044466:Asian People; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D000451:Mineralocorticoid Receptor Antagonists
chemical_list: D000451:Mineralocorticoid Receptor Antagonists